Company Filing History:
Years Active: 2020-2023
Title: Inventor Spotlight: Godrej Khambatta in San Diego, CA
Introduction
Godrej Khambatta is an innovative inventor based in San Diego, California, recognized for his contributions to the field of therapeutic compound research. With a focus on the interactions of small molecules with cereblon, Khambatta has secured two patents that underscore his expertise and dedication.
Latest Patents
Khambatta's latest patents revolve around advanced methods for measuring small molecule affinity to cereblon. One notable patent details a complex that features a CRBN (cereblon) with a europium-anti-his antibody at its N-terminus, paired with a Cy5-conjugated small molecule. This innovative approach facilitates the binding of the Cy5-conjugated small molecule to the CRBN and provides techniques for identifying therapeutic compounds.
Career Highlights
Khambatta is currently affiliated with Celgene Corporation, a prominent company focused on biopharmaceuticals. His work has significantly contributed to the advancement of therapeutic applications in medicine, particularly in understanding and targeting protein interactions relevant to disease treatments.
Collaborations
Throughout his career, Khambatta has collaborated with notable colleagues such as Philip Chamberlain and Mary Matyskiela. These partnerships exemplify the importance of teamwork in research and development, enhancing the impact of their collective discoveries in the innovation landscape.
Conclusion
As an inventor committed to improving medical science, Godrej Khambatta continues to make influential strides in his field. His patents not only reflect his innovative spirit but also his dedication to exploring therapeutic potentials that could benefit many. With ongoing collaboration and research, Khambatta remains a significant contributor to the realm of biomedical innovations.